Analysts offer mostly positive outlook on PRA Health Sciences
A number of analysts recently initiated coverage on CRO PRA Health Sciences, with most predicting that the company’s recent IPO will result in a steadily growing stock price.
Archives for December 9, 2014
Horizon Discovery enters crowded CHO cell line market
Horizon Discovery Group announced Monday that its bioproduction division has shipped its first commercially available engineered CHO (Chinese Hamster Ovary) cell line for use in manufacturing of antibodies.
From CPHI India
CPHI India: experts say ‘data fraud’ dragging down Indian manufacturing
Experts at CPHI India say companies failing manufacturing inspections need to be more honest with their data.